VA
Valmark Advisers’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
2,573
+139
| +6% | +$17.6K | ﹤0.01% | 528 |
|
|
2025
Q1 | $311K | Buy |
2,434
+892
| +58% | +$114K | ﹤0.01% | 509 |
|
|
2024
Q4 | $204K | Buy |
+1,542
| New | +$204K | ﹤0.01% | 584 |
|
|
2024
Q2 | – | Sell |
-1,622
| Closed | -$223K | – | 566 |
|
|
2024
Q1 | $223K | Sell |
1,622
-37
| -2% | -$5.08K | ﹤0.01% | 509 |
|
|
2023
Q4 | $225K | Buy |
+1,659
| New | +$225K | ﹤0.01% | 470 |
|
|
2023
Q3 | – | Sell |
-1,626
| Closed | -$206K | – | 475 |
|
|
2023
Q2 | $206K | Buy |
1,626
+50
| +3% | +$6.35K | ﹤0.01% | 460 |
|
|
2023
Q1 | $204K | Buy |
+1,576
| New | +$204K | ﹤0.01% | 461 |
|
|
2022
Q2 | – | Sell |
-2,045
| Closed | -$266K | – | 417 |
|
|
2022
Q1 | $266K | Buy |
+2,045
| New | +$266K | ﹤0.01% | 382 |
|
|
2021
Q4 | – | Sell |
-1,376
| Closed | -$222K | – | 409 |
|
|
2021
Q3 | $222K | Buy |
1,376
+1
| +0.1% | +$161 | ﹤0.01% | 365 |
|
|
2021
Q2 | $225K | Hold |
1,375
| – | – | ﹤0.01% | 360 |
|
|
2021
Q1 | $207K | Buy |
+1,375
| New | +$207K | ﹤0.01% | 360 |
|
|
2018
Q4 | – | Sell |
-1,755
| Closed | -$214K | – | 206 |
|
|
2018
Q3 | $214K | Sell |
1,755
-85
| -5% | -$10.4K | ﹤0.01% | 190 |
|
|
2018
Q2 | $202K | Buy |
+1,840
| New | +$202K | ﹤0.01% | 186 |
|